Skip to main navigation
Contineum Therapeutics logo
  • Overview
  • News & Events
    • News Releases
    • Events & Presentations
  • Financial Information
    • SEC Filings
    • Quarterly Results
    • Annual Reports
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • Corporate Governance
    • Governance Overview
    • Management
    • Board of Directors
    • Committee Composition
  • Shareholder Resources
    • Email Alerts
    • Contact IR

News Releases

News & Events
  • News Releases
  • Events & Presentations
January 8, 2025
Contineum Therapeutics Completes Enrollment in Phase 2 PIPE-307 VISTA Trial for the Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS)

Investor Contact

3565 General Atomics Court, Suite 200
San Diego, CA 92121

drafts ir@contineum-tx.com
phone_iphone Direct: +1.858.333.5280

Subscribe to our Email Alerts

Contineum Therapeutics logo
©2025 Contineum Therapeutics
linkedin opens in new window
Terms of Use Privacy Policy
Search Investors